Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Total Long-Term Liabilities : ¥152.9 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Zhejiang Shapuaisi Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥152.9 Mil.

Zhejiang Shapuaisi Pharmaceutical Co Total Long-Term Liabilities Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Total Long-Term Liabilities Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

12.91

37.62

35.18

73.23

139.12

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial															70.48	127.62	125.73	139.12	152.86

Zhejiang Shapuaisi Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Zhejiang Shapuaisi Pharmaceutical Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Shapuaisi Pharmaceutical Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Total Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200

Website

https://www.zjspas.com

Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.

Executives

Huang Ming Xiong	Directors, senior managers
Wu Jian Guo	Director
Xu Hong Sheng	senior management
Hu Zheng Guo	Director
Ge Sheng Fang	Director
Feng Xiao	Supervisors
Chen De Kang	Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines